BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s stock price shot up 6.4% during mid-day trading on Monday . The company traded as high as $1.33 and last traded at $1.33. 32,688 shares changed hands during mid-day trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.25.
BioRestorative Therapies Price Performance
The company has a 50 day moving average price of $1.51 and a 200 day moving average price of $1.60. The firm has a market cap of $2.18 billion, a PE ratio of -1.24 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Read More
- Five stocks we like better than BioRestorative Therapies
- Conference Calls and Individual Investors
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- The Most Important Warren Buffett Stock for Investors: His Own
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- How to Calculate Stock Profit
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
